The CBCRP’s Strategy for Allocating Research Funds
The CBCRP’s Breast Cancer Research Council and staff set the priorities for allocating the Program’s research funds. The following ten criteria are used by the Breast Cancer Research Council to set priorities.
- California Specific: Fund research that utilizes resources particular to California and/or addresses a breast cancer need that is specific but not necessarily unique to the burden of breast cancer in California.
- Career Development: Fund research that helps recruit, retain, and develop high-quality California-based investigators who engage in breast cancer research.
- Collaboration: Fund research that uses multi-disciplinary approaches and helps fosters collaboration among California scientists, clinicians, advocates, community members, patients, survivors, and others.
- Disparities: Fund research that addresses disparities, inequalities, and/or underserved populations in California.
- Innovation: Fund innovative research (i.e., new drugs, new strategies, new paradigms, new applications of tested strategies in new populations and contexts).
- Non-duplicative: Fund research that complements, builds on, and/or feeds into, but does not duplicate, other research programs.
- Outcome Driven: Fund research that will improve public health outcomes (e.g. preventing breast cancer, detection of breast cancer, effective treatments, and quality of life).
- Policy: Fund research and evaluation that will have policy implications for breast cancer in California.
- Responsive: Fund research that is responsive to the perceived breast cancer research needs, opportunities, and expectations of the CBCRP as identified by scientists and the public in California.
- Translation: Fund research that is on a critical path for practical application and leads to more effective products, technologies, interventions, or policies and their application/delivery to Californians.
To ensure that the CBCRP fulfills all of the criteria, the Council devised a two-part funding strategy, the Special Research Initiatives and Core Funding.
Special Research Initiatives
Investigate Crucial, Neglected Questions
The CBCRP is investing 30 percent
of its research funds in the Program’s
Special Research Initiatives.
The initiatives utilize California’s
diverse populations and extensive
research infrastructure to focus on
challenging questions that have
thwarted traditional research approaches.
The initiatives investigate
two interconnected research areas:
- Environmental links to breast cancer;
- The reasons why some groups of women are more likely to get or die from breast cancer, based on characteristics that include geographic location, race, and ethnicity.
In April 2008, the ten groundbreaking initiatives were announced to the media and the public. Three are concerned with environmental links to breast cancer:
- Chemicals Policy and Breast Cancer convenes an expert working group to identify biological pathways through which chemicals contribute to breast cancer and to identify the best currently available chemical safety tests. The results will be used to bring breast cancer to the forefront in the California government’s statewide development of a new green policy on chemicals. The CBCRP has set aside $160,000 plus indirect costs to fund one award.
- Making Chemicals Testing Relevant to Breast Cancer will invite researchers to submit proposals to develop the most comprehensive battery of accurate, reliable, rapid, and cost-effective existing tests that can be performed on chemicals to see if they cause changes in the body that contribute to breast cancer. The CBCRP will issue a request for proposals and fund up to nine awards at $300,000 in direct costs each and up to six awards at $450,000 in direct costs each.
- Environmental Causes of Breast Cancer across Generations will test tissue samples collected 40-50 years ago to find out whether exposure to certain chemicals during pregnancy increases the child’s risk for breast cancer in later life. The CBCRP allocated up to $5 million for the Child Health and Development Study (Barbara Cohn, Principal Investigator) to carry out a study on the relationship of pre-natal exposures to PCBs and DDT to breast cancer rates in women who are in their 40s today.
Three initiatives investigate the reasons why some groups of women are more likely to get or die from breast cancer, based on characteristics that include geographic location, race, and ethnicity:
- An Integrated Approach to Understanding Behavioral, Social, and Physical Environment Factors and Breast Cancer among Immigrants investigates a trend among women who immigrate to the U.S. from countries with lower breast cancer rates. The longer the women live here, the higher their rates of the disease. Their daughters born here have higher rates still. Researchers will be invited to submit proposals for pilot studies that describe changes in California immigrant women’s behavior, social lives, and physical environment that may cause their increase in breast cancer. The CBCRP allocated funds for up to three awards for up to $400,000 in direct costs each.
- Demographic Questions for California Breast Cancer Research is designed to remedy a current problem, where researchers seeking to understand ethnic differences in breast cancer need demographic information that is often not standardized or available. The CBCRP allocated up to $300,000 to convene an expert panel to identify the demographic measures that will best allow better health predications among diverse populations.
- Understanding Racial and Ethnic Differences in Stage-Specific Breast Cancer Survival: A Pilot Study. In general, the lower the stage of a breast tumor when a woman is diagnosed, the more likely she is to survive. However, women from some racial and ethnic groups are less likely to survive than women from other racial and ethnic groups diagnosed at the same stage. To find out why, this feasibility study will determine whether data from existing California studies can be combined to provide a more complete picture. If so, the CBCRP will fund a major study combining the data for up to $3.9 million in total costs. The CBCRP allocated funds to support up to six researchers for up to $20,000 in direct costs each and one convener for up to $80,000 in direct costs for the feasibility study. If the pilot is successful, the CBCRP will fund a major study to combine and analyze the data for up to $3.9 million in total costs.
Four Special Research Initiatives investigate intersections of multiple factors that impact breast cancer:
- New Statistical Models to Address Disease Complexity. Environmental exposures, such as contact with toxic chemicals, can contribute to breast cancer. So can social exposures, such as living with the stress of racism. Researchers will be invited to submit proposals to develop and test new statistical analysis strategies to better address how multiple exposures across a woman’s life course may cause breast cancer. The CBCRP allocated funding for up to five awards of $150,000 to $300,000 in direct costs.
- Toward a New Paradigm of Breast Cancer Breast Cancer Causation and Prevention will convene a diverse, interdisciplinary panel that includes social scientists, environmental scientists, and experts on ethnic and other disparities in breast cancer. The panel will develop a model of breast cancer causation based on complexity theory that takes into account many events, on many levels, over the life course. The CBCRP allocated funds for one award for up to $230,000 in direct costs.
- Environmental Exposures and Breast Cancer
among a Large, Diverse Cohort of Women
funds two pilot studies to find the most
promising research cohort to use for investigating
California women’s environmental
exposures and breast cancer.
- One considers the statewide California Teachers Study, where over 133,000 women periodically provide biological samples (such as blood) and information about their lives to the study’s researchers at several universities. The CBCRP will award $100,000 in direct costs to support this pilot.
- The second pilot study considers Kaiser Permanente Northern California’s study of over 200,000 women, the Research Program on Genes, Environment and Health (RPGEH). If one of these pilot studies yields promising results, a larger study will be funded in 2010. The CBCRP will award up to $100,000 in direct costs for this pilot.
If one of these pilot studies yields promising results, a larger study will be funded in 2010 at up to $6 million in total costs.
The CBCRP launched the Special Research Initiatives in 2005 because the Program’s previous efforts to increase research addressing these questions had not led to enough progress. California is an ideal laboratory for these under-researched questions. The state has varied geography, heavily industrialized areas, and a large agricultural area. It has a mix of urban, suburban, small town, and rural communities. The state’s population is ethnically and racially diverse. California also has communities with some of the highest rates of breast cancer in the nation.
The initiatives are the result of a thoughtful, thorough planning process that included analyzing years of nationwide and CBCRP-funded breast cancer research, and collecting feedback from breast cancer advocates, researchers, healthcare providers, policy makers, other funders, and the public.
To select the research that will lead to the most progress against breast cancer, the Program followed a carefully-crafted, two-year, publiclyaccessible strategy development process. A steering committee of researchers and advocates from across the nation guided this process of developing strategy. The members of this committee include:
- Olufunmilayo I. Olopade, M.D., Walter L. Palmer Distinguished Service Professor of Medicine, University of Chicago Medical Center, who recently received a MacArthur fellowship for her work translating findings on the molecular genetics of breast cancer in African American and African women into innovative clinical practices in the United States and abroad.
- Susan Shinagawa, co-founder/co-chair of the Asian & Pacific Islander National Cancer Survivors Network, is widely recognized as the nation’s leading Asian American cancer and chronic pain advocate and activist.
- David R. Williams, Ph.D., Norman Professor of Public Health at the Harvard School of Public Health and a Professor of African American Studies and Sociology at Harvard University, is a leader in research into how racial discrimination affects heart disease and other health conditions.
- Julia G. Brody, Ph.D., Executive Director, Silent Spring Institute, is one of the world’s experts on breast cancer and the environment.
- Sandra Steingraber, Ph.D., is author of the book Living Downstream: An Ecologist Looks at Cancer and the Environment, and an environmental activist with a national reputation.
The CBCRP’s director, Marion H.E. Kavanaugh- Lynch, also serves on the steering committee.
A major step in selecting the topics to be studied under the CBCRP’s Special Research Initiatives was the drafting of a review of previous research into the impact of the environment on breast cancer and the reasons why some groups of women bear a greater burden of the disease. This document, titled “Identifying Gaps in Breast Cancer Research,” runs to hundreds of pages, considers the results of thousands of research studies, summarizes the latest thinking on these questions, and makes recommendations for research to be pursued. “Identifying Gaps in Breast Cancer Research” is available to the public on the CBCRP Web site. A panel of science advisors, composed of experts from California and across the nation, reviewed and shaped “Identifying Gaps in Breast Cancer Research.” A list of the science advisors, staff, and consultants who wrote and shaped “Identifying Gaps in Breast Cancer Research” is found in Appendix A.
The CBCRP also gathered ideas for research to be conducted under the Special Research Initiatives from a variety of sources. Town hall stakeholder meetings, teleconferences, online brainstorming, and a session at the CBCRP’s most recent symposium all encouraged the California public and breast cancer experts to submit ideas. Those who participated in this process were later able to rate the ideas submitted. Participants included women affected by breast cancer, investigators, clinicians, government officials, and interested members of the public across California and the nation.
During 2008, a 33-member strategy team of scientists, advocates, and clinicians from California and across the nation made specific recommendations for the ten research initiatives. The strategy team members are listed in Appendix B.
As a result of the CBCRP’s leadership in research into the role of the environment in breast cancer, the Program’s director, Marion H.E. Kavanaugh- Lynch, has been appointed to the nine-member California Environmental Contaminant Biomonitoring Program Scientific Guidance Panel. The panel assists the Department of Health Services and California Environmental Protections Agency by providing scientific peer reviews and making recommendations regarding the design and implementation of the California Environmental Contaminant Biomonitoring Program.
Core Funding
After setting aside 30 percent of CBCRP research funds for the Special Research Initiatives, the CBCRP dedicates the remaining 70 percent to challenging investigators to use the funds to maximum effect. During its fifteen-year history, the CBCRP has developed and fine-tuned a funding strategy designed to stimulate innovative research.
Each core funding research project must fall under one of the CBCRP’s Priority Issue areas:
- The Community Impact of Breast Cancer
- Etiology and Prevention
- Biology of the Breast Cell
- Detection, Prognosis, and Treatment
Each core funding research project must also qualify as one of the CBCRP types of awards:
- Community Research Collaboration (CRC) award: Brings community organizations— such as breast cancer advocacy organizations, community clinics, or organizations serving under-represented women—together with experienced scientists to investigate breast cancer problems that are important to that community, using culturally-appropriate research methods. Pilot CRC awards are funded up to 18 months and up to $150,000 in direct costs. Full CRC awards are funded up to three years for up to $600,000 in direct costs.
- Innovative Developmental and Exploratory Award (IDEA): Funds promising high-risk/ high-reward research to “road test” innovative concepts. Applicants must show how their project is part of a step-by-step research process that will lead to practical applications. IDEAs are funded for up to 18 months and up to $100,000—and for studies using animals or humans, $150,000—in direct costs.
- IDEA–competitive renewal: Allows recentlyfunded recipients of CBCRP IDEA grants to compete for additional funding, if the project has succeeded in meeting key milestones in a research process that will lead to practical applications. IDEA-competitive renewal awards are available for up to two years and up to $200,000—and for studies using animals or humans, $250,000—in direct costs.
- Postdoctoral Fellowship award: Funds advanced training under a breast cancer mentor. Total postdoctoral tenure (prior training plus new CBCRP funding) is limited to five years, and the maximum award duration is three years at $45,000 per year.
- Dissertation award: Supports the completion of dissertation research by masters or doctoral degree candidates. Dissertations are funded up to $38,000 per year for up to two years.
- Joining Forces Conference award: Supports a conference, symposium, retreat, or other meeting to link breast cancer researchers, non-breast cancer investigators, and community members for the purpose of stimulating new ideas and collaborations.
- Translational Research award: Funds research that will take basic science findings quickly toward treatment, diagnosis, prevention or another application that can directly impact breast cancer, either in a medical clinic setting or through a public health measure.
Core Funding by Priority Issue and by Award Type
Below, two tables present statistics on the 42 projects funded during 2008 by Priority Issue and by
Award Type.

Influencing the Research System Nationwide
One goal underlying the CBCRP’s funding strategy is the leveraging of Program funds to influence the research system nationwide. The CBCRP is part of a much larger research system. The federal government funds breast cancer research through agencies like the National Cancer Institute and the Department of Defense. Nonprofit organizations and for-profit corporations also fund breast cancer research. Although the CBCRP is the largest state funding source for breast cancer research in California, these funds make up only a small part of the funds granted through the larger system. The CBCRP tries to influence this larger research system to move in new, creative directions.
An example is the CBCRP’s Innovative, Developmental, and Exploratory Awards (IDEAs). These awards were specifically designed to fund research that has a high potential for scientific payoff— and also a high potential for failure. When the CBCRP began funding breast cancer research in 1995, less than 10 percent of research proposals submitted to the nation’s funding agencies were successful. This led the people who decided what got funded—panels of research experts—to look for proposals that seemed most likely to succeed. Research scientists had to have done a significant portion of the research, and have strong preliminary data, before they could even get a grant. This made it hard for anyone to get funding in order to try out a high-risk idea. However, high-risk ideas are often the source of scientific breakthroughs. The CBCRP’s IDEAs meet a need by funding creative new research approaches.
If the research funded by an IDEA succeeds, the researcher may well be able to get another research funding agency to fund the next step. For example, John Boone, Ph.D., and Karen Lindfors, M.D., of the University of California, Davis, received a CBCRP IDEA award that allowed them to build the first dedicated computerized tomography (CT) breast scanner. CT scanners are a special type of x-ray machine that produce threedimensional pictures. In contrast, mammogram x-rays produce a two-dimensional picture and may not show a tumor obscured by other breast tissue. Standard mammography detects tumors at an average size of about 11 millimeters in diameter, about the size of a garbanzo bean (or chick pea). Breast CT aims to detect tumors at an average diameter of 5 millimeters, about the size of a small pea. The smaller a tumor is when it is discovered, the more treatment options a woman has—and the better her odds of surviving breast cancer. CBCRP funding allowed the researchers to solve problems that included lowering the previously unacceptably high radiation dose involved in breast CT scanning. As a result, Boone and Lindfors have received $6 million from the National Institutes of Health to further develop their CT scanner, which is currently being tested in clinical trials.
The CBCRP uses additional methods to get creative new research going. These include encouraging researchers in California to submit exciting new ideas. The CBCRP also developed a new scoring system to help reviewers read proposals with a perspective toward rewarding high-risk research. In addition, the Program’s Special Research Initiatives are a multi-year effort to stimulate new research in previously underinvestigated areas that have a high potential to lead to breakthroughs in breast cancer causes and prevention.
Enlarging the Pool of Breast Cancer Researchers
Another major goal of the CBCRP is to increase the number of talented scientists engaged in breast cancer research. Some of the Program’s grants have allowed investigators to specialize in, or concentrate much of their efforts on, breast cancer research. For example, Anastasia Kralli, Ph.D., of the Scripps Research Institute, has been interested in investigating mechanisms of action of estrogen-related receptors in the muscle and central nervous system. CBCRP funding has encouraged her to expand her investigations to include breast cancer. Using her 2006 CBCRP IDEA grant, Dr. Kralli was able to demonstrate that when the activity of these proteins is selectively increased in breast tumor cells, it keeps these cells from growing and forming tumors. Dr. Kralli’s findings also suggest that compounds based on parts of the molecular structure of estrogen-related receptors could be used to treat breast cancer.
Leveraging Funds for Promising Research
An additional goal of the CBCRP’s research
strategy is encouraging and inspiring other
research funding agencies to support cuttingedge
research. For example, in 2008, the Avon
Foundation, which funds breast cancer research
nationwide, joined the CBCRP in supporting the
Program’s ground-breaking Special Research Initiatives.
The foundation, long a funder of breast
cancer research, agreed that not enough has
been done in the areas of environmental links to
breast cancer and the reasons why some groups
of women bear a greater burden of the disease.
The Avon Foundation awarded the CBCRP a
$500,000 grant earmarked for three of the ten
CBCRP Special Research Initiatives. Two of the
initiatives support research exploring environmental
exposures and breast cancer among large
and diverse groups of women at several points
through their life. The third project will combine
data from multiple California studies to explore
answers to why people from different racial and
ethnic groups have different survival outcomes,
despite being diagnosed with breast cancer at
the same stage.
